The Readout Loud
STAT
Add to My Podcasts
Episodes
About
Reviews
Promote
Episode 118: Remdesivir’s controversial cost, early vaccine promise, and AI at the end of life
22 minutes
Posted Jul 2, 2020 at 5:23 pm.
0:00
22:25
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
What’s a fair price for remdesivir? How do we know whether vaccines work? And does AI have a place in end-of-life care?
Previous
Episode 117: Covid-19’s U.S. surge, GSK’s mystery whistleblower, and cancer care under coronavirus
Next
Episode 119: Trump's FDA pressure, a microcosm of the pandemic, and squabbling over a vaccine
← See all 424 episodes of The Readout Loud
